Clinical Trials Logo

Bioavailability clinical trials

View clinical trials related to Bioavailability.

Filter by:

NCT ID: NCT02138396 Completed - Bioavailability Clinical Trials

Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions

Start date: January 2014
Phase: N/A
Study type: Interventional

The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.

NCT ID: NCT02110316 Withdrawn - Critically Ill Clinical Trials

Bioavailability of Voriconazole

Start date: June 2015
Phase: Phase 4
Study type: Interventional

The objective of this study is to obtain the absolute bioavailability of voriconazole in critically ill ICU patients, because pharmacokinetics can be different in critically ill patients due to alterations in function of various organs and body systems compared with healthy volunteers.

NCT ID: NCT02064907 Completed - Bioavailability Clinical Trials

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

Start date: February 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacokinetics (PK) and Pharmacodynamics (PD) of dexlansoprazole delayed-release orally disintegrating (OD) tablets administered on the tongue and swallowed without water.

NCT ID: NCT02010944 Completed - Healthy Subjects Clinical Trials

A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Start date: September 2012
Phase: Phase 1
Study type: Interventional

This study compares the pharmacokinetics (PK), safety and tolerability of fixed dose combination (FDC) tablets containing solifenacin succinate and mirabegron with the co-administration of single entity tablets (SET), at three dose strengths.

NCT ID: NCT01912144 Completed - Bioavailability Clinical Trials

Absorption of Phenolic Acids From Coffee in Humans

Start date: September 1, 2012
Phase: N/A
Study type: Interventional

Phenolic acids are naturally-occurring constituents of plant-derived foods and beverages and are characterised by a phenol ring in their structure. The phenolic compounds we are going to focus on in this study are the Chlorogenic acids (CGAs), a family of esters conjugates formed between a Hydroxycinnamic acid and quinic acid (1) and that show a strong antioxidant activity (2). HCAs represent about 50% of the total polyphenolic coumpounds intake in a typical UK diet (3) and for people who drink it, coffee is a/the major dietary source of/for HCAs (4). A few studies suggest protective effects for cardiovascular diseases (5), neurodegenerative diseases, type 2 diabetis and liver and kidneys cancer risk. However, many data in the field are obtained from in vitro and/or in animal, and it is difficult and dangerous to extrapolate between these and risk in humans of development or progression of particular health conditions, more human studies are therefore needed. We aim to compare people that metabolise the best CGAs from coffee to those that metabolise them the least well. This will be achieved by measuring the metabolites in urine. The effect of CGAs on the human body does not only depend on the amount ingested, but also on the quality of the metabolism, we therefore also want to determine which mechanisms are responsible for inter-individual variations in order to identify any link with health biomarkers, these including non-cellular inflammation and cardiovascular risk indicators. For this cohort study funded by the University of Leeds, approximately 60 healthy volunteers will be recruited at the School of Food Science & Nutrition. If they meet the selection criteria, participants will be asked to undergo a 36-hour wash-out period. During those 36 hours, participants won't be allowed to drink coffee, they will be asked to follow a diet low in phenolic acids and keep a record of their meals. On the first day of the study, a single dose of coffee rich in antioxidants will be given to the participant and urine will be collected from that time until 36 hours after coffee consumption. Participants will be followed again after 5 to 6 weeks.

NCT ID: NCT01873274 Completed - Bioavailability Clinical Trials

Comparative Study Menaquinone-7

Start date: April 2012
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the absorption of menaquinone-7 from a nutrient-enriched dairy product compared to a general dairy product enriched with menaquinone-7 and a menaquinone-7-containing supplement.

NCT ID: NCT01856816 Completed - Clinical trials for Dietary Modification

Effect of Meal Patterning on Carotenoid Absorption From Vegetables

S26
Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine how different meal patterns influence the absorption of beneficial plant pigments (carotenoids) from vegetables. The hypothesis is that carotenoid absorption will be lower when daily vegetables are consumed in one meal compared two smaller meals throughout the day.

NCT ID: NCT01852903 Completed - Bioavailability Clinical Trials

Comparative Bioavailability of Two Forms of Vitamin C

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare levels of vitamin C in the blood over the 24 hour period following a single 1000 mg dose of vitamin C from ascorbic acid, calcium ascorbate and placebo.

NCT ID: NCT01789359 Completed - Bioavailability Clinical Trials

Urinary Excretion of Anthocyanins During Long Term Blueberry Feeding

Start date: November 2012
Phase: N/A
Study type: Interventional

Essentially all of the published data on anthocyanin absorption in humans are from short term studies - a few days or less, most typically 24 h. However human studies demonstrating clinical effects are typically conducted for several weeks or even months. To examine how anthocyanin absorption and metabolism may be affected this study will examine urinary excretion of anthocyanins over one month, followed by a one week washout, and then one more dose of blueberry juice.

NCT ID: NCT01743924 Completed - Bioavailability Clinical Trials

Bioavailability of Chemopreventive and Nutritional Compounds in Broccoli

Start date: July 2011
Phase: Phase 0
Study type: Interventional

The aim of this study was to determine the absorption of isothiocyanates (ITC) after ingestion of kailan-hybrid broccoli through the analysis of the correspondent urinary biomarkers. Furthermore, the effect of cooking (microwave) on the mentioned metabolic fate of these ITC was studied comparing to the uncooked vegetable.